LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
Mumbai: The global pharmaceutical company Lupin Limited (Lupin) has announced the release of Rocuronium Bromide injection in two variations: 50 mg/5 mL (10 mg/mL) and 100 mg/10 mL (10 mg/mL) ...
Fresenius Kabi, a provider of injectable medications, has announced the U.S. launch of its Rocuronium Bromide Injection, a product offered with RFID-enabled labels. Rocuronium Bromide Injection is ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. DBL Rocuronium Bromide contains the active ingredient rocuronium ...
https://www.thehindubusinessline.com/markets/lupin-ltd-introduces-rocuronium-bromide-injection-shares-up/article67511740.ece Copy Lupin Limited’s shares were up by ...
- Launch accelerated in response to market impacts anticipated from the natural disaster at Pfizer's Rocky Mount, NC drug manufacturing facility - KinetiX Rocuronium Bromide Injection will be offered ...
The injections are the generic version of Zemuron Bromide Injection, 50 mg/5 mL and 100 mg/10 mL of Organon USA Inc, and will be used as an adjunct to general anaesthesia. The injections are the ...
Caplin Steriles, a subsidiary of Chennai-based Caplin Point Laboratories Ltd. on Saturday announced that it has received final approval from the United States Food and Drug Administration (USFDA) for ...
SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...
RICHMOND, Va.--(BUSINESS WIRE)--Phlow, a U.S.-based, public benefit impact-driven pharmaceutical company, announced the launch of key essential medicines, sequentially over the coming quarter, for the ...
August 20, 2007 — Health Canada has approved a new indication for a cannabis-derived buccal spray, allowing its use as adjunctive treatment for pain in patients with advanced cancer not responding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results